Recent News

• 03.25.2026 - INVO Fertility Announces a 1:5 Reverse Stock Split Effective Pre-Market Opening on March 27, 2026
• 03.05.2026 - INVO Fertility Announces Availability of Advanced Incubation Technology at its Wisconsin Clinic
• 03.03.2026 - INVO Fertility’s Wisconsin Clinic Joins Progyny Network
• 02.19.2026 - INVO Fertility Closes Acquisition of Indiana-Based Fertility Clinic “Family Beginnings”
• 02.11.2026 - INVO Fertility Announces Patent Issuance for Modified INVOcell® Device
• 02.04.2026 - INVO Fertility Issues Shareholder Letter Highlighting Strengthened Fundamental Position and Strategic Outlook for Growth
• 01.29.2026 - INVO Fertility Enters into $7.5 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules
• 01.13.2026 - INVO Fertility to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026

Recent Filings

• 02.24.2026 - 8-K Current report
• 02.24.2026 - EX-99.1 EX-99.1
• 02.17.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.12.2026 - 424B3 Prospectus [Rule 424(b)(3)]
• 02.10.2026 - EFFECT Notice of Effectiveness
• 02.06.2026 - S-8 Securities to be offered to employees in employee benefit plans
• 02.02.2026 - S-1 General form for registration of securities under the Securities Act of 1933
• 01.30.2026 - EX-99.1 EX-99.1
• 01.30.2026 - 8-K Current report
• 01.26.2026 - 8-K Current report